Association of IL-8 (-251)T/A polymorphism with susceptibility to and aggressiveness of nasopharyngeal carcinoma

Hum Immunol. 2007 Sep;68(9):761-9. doi: 10.1016/j.humimm.2007.06.006. Epub 2007 Jul 18.

Abstract

Interleukin-8 (IL-8) is an angiogenic chemokine that plays a potent role in both development and progression of many human malignancies including nasopharyngeal carcinoma (NPC). In the present study, we evaluated the susceptibility and prognostic implications of the (-251) T/A genetic variation in IL-8 in NPC. We used the allele-specific polymerase chain reaction to characterize the variation of the IL-8 promoter region for 160 unrelated Tunisian patients with NPC and 169 healthy control subjects. There was a significant association between the homozygotes IL-8 (-251) AA genotype and nasopharyngeal carcinoma (OR = 2.46; P = 0.004). The presence of the IL-8 (-251) AA genotype was highly associated with elevated NPC risk for male patients. A significant association was demonstrated between the IL-8 (-251) AA genotype and the aggressive forms of NPC as defined by large tumor size, lymph node metastasis, and advanced stages. Moreover, the presence of the IL-8 (-251) AA genotype indicated a significant association with decreased overall survival. Our findings suggest that the IL-8 promoter polymorphism is associated with increased nasopharyngeal carcinoma risk, particularly in males, as well as disease progress, supporting our hypothesis for IL-8 involvement in NPC pathogenesis.

Publication types

  • Evaluation Study

MeSH terms

  • Adult
  • Carcinoma / diagnosis
  • Carcinoma / genetics*
  • Carcinoma / pathology*
  • Disease Progression
  • Female
  • Genetic Predisposition to Disease*
  • Humans
  • Interleukin-8 / metabolism*
  • Male
  • Nasopharyngeal Neoplasms / diagnosis
  • Nasopharyngeal Neoplasms / genetics*
  • Nasopharyngeal Neoplasms / pathology*
  • Neoplasm Invasiveness
  • Polymorphism, Single Nucleotide*
  • Prognosis
  • Promoter Regions, Genetic
  • Risk Factors

Substances

  • Interleukin-8